The CAR-T cell contains scFv, two stimulation molecules, and the CD3ζ structural domain, along with co-stimulant like OX40, ICOS, CD27, CD40-MyD88, etc. Previous studies have indicated enhanced and longer-lasting anti-tumor efficacy of these series-built CAR-T cells (14–16). Here, CD247 is linked to neoplasm.